Browse by all authors Browse By Author/Contributor/Editor Name - Franks,+P.+W.

Browse Results (2 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Barraclough, David R., Bertouch, James V., Brooks, Peter, Brown, Mark A., Cleland, Leslie G., Clemens, Laurie E., Crowley, Steven J., Day, Richard O., DeJager, Julien P., Edmonds, John P., Fletcher, Peter J., Franks, Gary R., Harris, David C., Horowitz, John D., Johnston, Michael D., Kerr, Stephen J., Littlejohn, Geoff O., MacDonald, Graham J., McColl, Geoff J., Sambrook, Phillip N., Shakib, Sepehr, Verso, Murray W. and Yeomans, Neville D. (2002) Considerations for the safe prescribing and use of COX-2-specific inhibitors. Medical Journal of Australia, 176 7: 328-331.     12 Cited 21 times in Scopus21
Elgzyri, T., Parikh, H., Zhou, Y., Nitert, M. Dekker, Ronn, T., Segerstrom, A. B., Ling, C., Franks, P. W., Wollmer, P., Eriksson, K. F., Groop, L. and Hansson, O. (2012) First-degree relatives of type 2 diabetic patients have reduced expression of genes involved in fatty acid metabolism in skeletal muscle. Journal of Clinical Endocrinology & Metabolism, 97 7: E1332-E1337. doi:10.1210/jc.2011-3037     11 Cited 13 times in Scopus13 1